Bacterial Infections  >>  Thravixa (AVP-21D9)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Thravixa (AVP-21D9) / Emergent Biosolutions
NCT01202695: Safety and Pharmacokinetics Study of Human Monoclonal Antibody (AVP-21D9)

Completed
1
50
US
AVP-21D9, Placebo, Placebo comparator
Emergent BioSolutions, National Institutes of Health (NIH)
Anthrax
06/11
06/11

Download Options